Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome
- 1 November 2003
- journal article
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 31 (3), 351-356
- https://doi.org/10.1016/j.bcmd.2003.08.001
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Down Syndrome and the Transient Myeloproliferative Disorder: Why Is It Transient?Journal of Pediatric Hematology/Oncology, 2002
- Transient Myeloproliferative Disorder, a Disorder With Too Few Data and Many Unanswered Questions: Does It Contain an Important Piece of the Puzzle to Understanding Hematopoiesis and Acute Myelogenous Leukemia?Journal of Pediatric Hematology/Oncology, 2002
- Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1mutationBlood, 2001
- The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's SyndromeBritish Journal of Haematology, 2000
- Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1Nature Genetics, 2000
- Consequences of GATA-1 Deficiency in Megakaryocytes and PlateletsBlood, 1999
- Role of GATA-1 in Proliferation and Differentiation of Definitive Erythroid and Megakaryocytic Cells In VivoBlood, 1998
- A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet developmentThe EMBO Journal, 1997
- A “knockdown” mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1Proceedings of the National Academy of Sciences of the United States of America, 1997
- Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1.Proceedings of the National Academy of Sciences of the United States of America, 1996